DraftKings recovers quickly - here’s how to play it today
In this edition of the Alpha Letter, we cover:
Options: The option flow told us to buy DraftKings
Commodities: Lumber prices fell dramatically. Is this the end of inflation?
Dividend Growth: This Canadian iron ore company just bumped its dividend by 75%
But first, a word from our sponsor:
Psychedelic Medicine: The Next Investing Megatrend
Finding the next megatrend is what the Big Boys of Wall Street do very well... and sometimes the smartest thing to do is to follow the money.
Five years ago it was Cannabis. Today it’s Psychedelic Medicine.
Research has shown the incredible promise psychedelic medicines have to help with a variety of mental health indications.
The opportunity to help turn the mental health tide is big. For example, over 300 million people suffer from depression worldwide and yet…
50-66% of patients on traditional antidepressants never make a full recovery and 33% of adults with MDD are “treatment-resistant.” There’s also been a 20% increase in the use of anti-anxiety and antidepressant drugs during COVID-19.
The need for new approaches has never been greater... and that’s where Ei.Ventures comes in.
Their flagship product “Psilly” (derived from the Psilocybin Mushroom) is a potential game changer for the millions struggling with mental illness.
Ei.Ventures recently made history as the first Psychedelic Medicine company based in the U.S. to launch a qualified Reg A+ Tier II public offering. Both accredited and non-accredited investors can participate. Click the link below for more information.
Get details about investing in Ei.Ventures here.
Options
Let’s take a look at what’s happening in the option markets.
As of Tuesday at close, here were the 10 most active names in the options market, sorted by total premium traded (data from Vigtec)
AMC is losing steam a bit but it is still the 2nd-most active stock in the options market. It barely crossed $1 billion in premium Tuesday - still a massive amount for a midcap stock, but much less than the $4 and $5 billion days we’ve seen over the last couple of weeks.
Call premium for AMC still looks very healthy at more than 900,000 contracts traded.
One interesting play in Tuesday’s options market is DraftKings (DKNG), Hindenburg Research, the same one that took down Trevor Milton of Nikola Motor, released a short report against the sports betting company yesterday.


DraftKings stock plunged at the open, but we noticed something interesting in the options market: Call activity was going crazy.
It seemed that a group of traders (or just one large trader) was betting on DKNG to quickly recover. Sure enough, the stock gained as much as 9% from the low and closed down just 4.17%. All in all, a pretty average day for the volatile sports betting stock.
Put activity has obviously very high in the first few minutes of trading, but we could see that calls dominated later in the day while watching the trade tape.
Hindenburg’s short report alleged that DraftKings’ business is tied up in money laundering, organized crime, and illegal sports betting.
I think that DraftKings stock wasn’t destroyed by this report for a couple reasons. One, I think many investors already expect that companies operating in areas like sports betting are making money from legally grey areas, if not from completely illegal areas.
The second is that this alleged wrongdoing actually benefits shareholders. If DraftKings makes money from illegal gambling, that revenue flows to the income statement and benefits shareholders.

It’s very different than wrongdoing that harms shareholders, such as Hindenburg’s report about Nikola Motor exaggerating projections and lying about the capability of its products.
Volatility like this creates opportunities. Watch DraftKings, or other stocks that are moving, and the respective option flows to figure out if there’s a clear next move you can take advantage of.
Here’s a snippet of the DraftKings trade tape today:
Commodities
Remember all the lumber jokes from last month?
Well the bubble in lumber pricing may have finally popped, or at least subsided for a bit.

The S&P commodity index (SPGSCI) is trading down this week as other commodity prices have taken a breather. The pause here could be a break in the hyper-inflation case many have been warning about, but it’s still too early to tell what the correct narrative is.
On the one hand, we’d expect large price surges as the economy quickly reopens. It only makes sense that airline tickets, hotel stays, and new homes would be bif up rapidly as suddenly millions of people could go on vacation and move around the country again.
However, the money printing by the federal government and over a decade of accommodative Fed policy makes some think that high inflation is inevitable, and this is just the start.
We’ll keep an eye on this for you and let you know what we see.
If you think inflation will continue to increase, it’s best to hold real assets like real estate, commodities, or stock in companies that control real assets and commodities. The worst position during high inflation is cash.
Dividend Growth
Looking for a high dividend yield play? Labrador Iron Ore Royalty (OTCMKTS: LIFZF) just bumped its dividend by 75% over the prior year.
Here’s the summary from Seeking Alpha:
The forward yield is currently 15.39%, but we expect buyers to jump in today to push the price up and the effective yield down. This announcement was made after the closing bell Tuesday, so this will definitely be a hot stock among yield-chasers tomorrow.
Labrador is in an industry that benefits from commodity pricing tailwinds, but the market doesn’t seem to be pricing that in correctly here.
Alpha Thought

Disclaimer: The publisher does not guarantee the accuracy or completeness of the information provided in this page. All statements and expressions herein are the sole opinion of the author or paid advertiser.
Alpha Letter is a publisher of financial information, not an investment advisor. We do not provide personalized or individualized investment advice or information that is tailored to the needs of any particular recipient.
THE INFORMATION CONTAINED ON THIS WEBSITE IS NOT AND SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, AND DOES NOT PURPORT TO BE AND DOES NOT EXPRESS ANY OPINION AS TO THE PRICE AT WHICH THE SECURITIES OF ANY COMPANY MAY TRADE AT ANY TIME. THE INFORMATION AND OPINIONS PROVIDED HEREIN SHOULD NOT BE TAKEN AS SPECIFIC ADVICE ON THE MERITS OF ANY INVESTMENT DECISION. INVESTORS SHOULD MAKE THEIR OWN INVESTIGATION AND DECISIONS REGARDING THE PROSPECTS OF ANY COMPANY DISCUSSED HEREIN BASED ON SUCH INVESTORS’ OWN REVIEW OF PUBLICLY AVAILABLE INFORMATION AND SHOULD NOT RELY ON THE INFORMATION CONTAINED HEREIN.
No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned.
Any projections, market outlooks or estimates herein are forward looking statements and are inherently unreliable. They are based upon certain assumptions and should not be construed to be indicative of the actual events that will occur. Other events that were not taken into account may occur and may significantly affect the returns or performance of the securities discussed herein. The information provided herein is based on matters as they exist as of the date of preparation and not as of any future date, and the publisher undertakes no obligation to correct, update or revise the information in this document or to otherwise provide any additional material.
The publisher, its affiliates, and clients of the a publisher or its affiliates may currently have long or short positions in the securities of the companies mentioned herein, or may have such a position in the future (and therefore may profit from fluctuations in the trading price of the securities). To the extent such persons do have such positions, there is no guarantee that such persons will maintain such positions.
Neither the publisher nor any of its affiliates accepts any liability whatsoever for any direct or consequential loss howsoever arising, directly or indirectly, from any use of the information contained herein.
By using the Site or any affiliated social media account, you are indicating your consent and agreement to this disclaimer and our terms of use. Unauthorized reproduction of this newsletter or its contents by photocopy, facsimile or any other means is illegal and punishable by law.
For Full Terms of Use Click HERE. For the Privacy Policy Click HERE.
alphaletter.co (“Alpha”) is a website owned and operated by Substack. Alpha is paid fees by the companies that make investment offerings on this website. Be aware that payment of these fees may put Alpha in a conflict of interest with the investor. By accessing this website or any page thereof, you agree to be bound by the Terms of Use and Privacy Policy, in effect at the time you access this website or any page thereof. The Terms of Use and Privacy Policy may be amended from time to time. Nothing on this website shall constitute an offer to sell, or a solicitation of an offer to buy or subscribe for, any securities to any person in any jurisdiction where such an offer or solicitation is against the law or to anyone to whom it is unlawful to make such offer or solicitation. Alpha is not an underwriter, broker-dealer, Title III crowdfunding portal or a valuation service and does not engage in any activities requiring any such registration. Alpha does not provide advice on investments or structure transactions. Offerings made under Regulation A under the U.S. Securities Act of 1933, as amended (the "Securities Act") are available to U.S. investors who are “accredited investors” as defined by Rule 501 of Regulation D under the Securities Act well as non-accredited investors, who are subject to certain investment limitations as set forth in Regulation A under the Securities Act. In order to invest in Regulation A offerings, investors may be asked to fill out a certification and provide necessary documentation as proof of your income and/or net worth to verify that you are qualified to invest in offerings posted on this website. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. Alpha does not verify the adequacy, accuracy or completeness of any information. Neither Alpha nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, valuations of securities or completeness of any information on this site or the use of information on this site. Neither Alpha nor any of its directors, officers, employees, representatives, affiliates or agents shall have any liability whatsoever arising from any error or incompleteness of fact, or lack of care in the preparation of, any of the materials posted on this website. Investing in securities, especially those issued by start-up companies, involves substantial risk. investors should be able to bear the loss of their entire investment and should make their own determination of whether or not to make any investment based on their own independent evaluation and analysis